Pharma official: Expect “substantial” revision of ICH stability and specification guidelines
Regulatory NewsJoanne S. EglovitchChemistry, Manufacturing and Controls (CMC)GlobalPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy